These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12638395)

  • 1. Single- and multiple-dose pharmacokinetics of etoricoxib, a selective inhibitor of cyclooxygenase-2, in man.
    Agrawal NG; Porras AG; Matthews CZ; Rose MJ; Woolf EJ; Musser BJ; Dynder AL; Mazina KE; Lasseter KC; Hunt TL; Schwartz JI; McCrea JB; Gottesdiener KM
    J Clin Pharmacol; 2003 Mar; 43(3):268-76. PubMed ID: 12638395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose proportionality of oral etoricoxib, a highly selective cyclooxygenase-2 inhibitor, in healthy volunteers.
    Agrawal NG; Porras AG; Matthews CZ; Woolf EJ; Miller JL; Mukhopadhyay S; Neu DC; Gottesdiener KM
    J Clin Pharmacol; 2001 Oct; 41(10):1106-10. PubMed ID: 11583479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the pharmacokinetics of digoxin in healthy subjects receiving etoricoxib.
    Schwartz JI; Agrawal NG; Wehling M; Musser BJ; Gumbs CP; Michiels N; De Smet M; Wagner JA
    Br J Clin Pharmacol; 2008 Dec; 66(6):811-7. PubMed ID: 18823299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption, metabolism, and excretion of etoricoxib, a potent and selective cyclooxygenase-2 inhibitor, in healthy male volunteers.
    Rodrigues AD; Halpin RA; Geer LA; Cui D; Woolf EJ; Matthews CZ; Gottesdiener KM; Larson PJ; Lasseter KC; Agrawal NG
    Drug Metab Dispos; 2003 Feb; 31(2):224-32. PubMed ID: 12527704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of etoricoxib, a novel, selective COX-2 inhibitor.
    Dallob A; Hawkey CJ; Greenberg H; Wight N; De Schepper P; Waldman S; Wong P; DeTora L; Gertz B; Agrawal N; Wagner J; Gottesdiener K
    J Clin Pharmacol; 2003 Jun; 43(6):573-85. PubMed ID: 12817520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effect of antacids on single-dose pharmacokinetics of etoricoxib.
    Schwartz JI; Agrawal NG; Kher UA; DeSmet M; Cavanaugh PF; Guillaume M; Ebel DL; Merschman SA; Wagner JA
    J Clin Pharmacol; 2007 Oct; 47(10):1342-6. PubMed ID: 17656618
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of chronic low back pain with etoricoxib, a new cyclo-oxygenase-2 selective inhibitor: improvement in pain and disability--a randomized, placebo-controlled, 3-month trial.
    Birbara CA; Puopolo AD; Munoz DR; Sheldon EA; Mangione A; Bohidar NR; Geba GP;
    J Pain; 2003 Aug; 4(6):307-15. PubMed ID: 14622687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacology of etoricoxib: a novel selective COX2 inhibitor.
    Patrignani P; Capone ML; Tacconelli S
    Expert Opin Pharmacother; 2003 Feb; 4(2):265-84. PubMed ID: 12562317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of etoricoxib in patients with hepatic impairment.
    Agrawal NG; Rose MJ; Matthews CZ; Woolf EJ; Porras AG; Geer LA; Larson PJ; Cote J; Dilzer SC; Lasseter KC; Alam I; Petty KJ; Gottesdiener KM
    J Clin Pharmacol; 2003 Oct; 43(10):1136-48. PubMed ID: 14517196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of etoricoxib in patients with renal impairment.
    Agrawal NG; Matthews CZ; Mazenko RS; Kline WF; Woolf EJ; Porras AG; Geer LA; Wong PH; Cho M; Cote J; Marbury TC; Moncrief JW; Alcorn H; Swan S; Sack MR; Robson RA; Petty KJ; Schwartz JI; Gottesdiener KM
    J Clin Pharmacol; 2004 Jan; 44(1):48-58. PubMed ID: 14681341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementary studies of the gastrointestinal safety of the cyclo-oxygenase-2-selective inhibitor etoricoxib.
    Hunt RH; Harper S; Callegari P; Yu C; Quan H; Evans J; James C; Bowen B; Rashid F
    Aliment Pharmacol Ther; 2003 Jan; 17(2):201-10. PubMed ID: 12534404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events.
    Hunt RH; Harper S; Watson DJ; Yu C; Quan H; Lee M; Evans JK; Oxenius B
    Am J Gastroenterol; 2003 Aug; 98(8):1725-33. PubMed ID: 12907325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of human liver cytochrome P4503A in the metabolism of etoricoxib, a novel cyclooxygenase-2 selective inhibitor.
    Kassahun K; McIntosh IS; Shou M; Walsh DJ; Rodeheffer C; Slaughter DE; Geer LA; Halpin RA; Agrawal N; Rodrigues AD
    Drug Metab Dispos; 2001 Jun; 29(6):813-20. PubMed ID: 11353749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etoricoxib.
    Cochrane DJ; Jarvis B; Keating GM
    Drugs; 2002; 62(18):2637-51; discussion 2652-3. PubMed ID: 12466002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and safety of JTE-522, a novel selective cyclooxygenase-2 inhibitor, in healthy male volunteers.
    Ikeda Y; Umemura K; Kondo K; Nakashima M; Kobayashi T; Takahashi M
    Br J Clin Pharmacol; 2002 Nov; 54(5):453-62. PubMed ID: 12445023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic and bioequivalence study of etoricoxib tablet in healthy Bangladeshi volunteers.
    Shohag MH; Islam MS; Ahmed MU; Joti JJ; Islam MS; Hasanuzzaman M; Hasnat A
    Arzneimittelforschung; 2011; 61(11):617-21. PubMed ID: 22232850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of modifying in vivo cytochrome P450 3A (CYP3A) activity on etoricoxib pharmacokinetics and of etoricoxib administration on CYP3A activity.
    Agrawal NG; Matthews CZ; Mazenko RS; Woolf EJ; Porras AG; Chen X; Miller JL; Michiels N; Wehling M; Schultz A; Gottlieb AB; Kraft WK; Greenberg HE; Waldman SA; Curtis SP; Gottesdiener KM
    J Clin Pharmacol; 2004 Oct; 44(10):1125-31. PubMed ID: 15342613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics.
    Bramer SL; Forbes WP
    Clin Pharmacokinet; 1999; 37 Suppl 2():13-23. PubMed ID: 10702883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of etoricoxib on the pharmacokinetics of oral contraceptives in healthy participants.
    Schwartz J; Hunt T; Smith WB; Wong P; Larson P; Crumley T; Mehta A; Gottesdiener K; Agrawal N
    J Clin Pharmacol; 2009 Jul; 49(7):807-15. PubMed ID: 19443681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examination of the effect of increasing doses of etoricoxib on oral methotrexate pharmacokinetics in patients with rheumatoid arthritis.
    Schwartz JI; Agrawal NG; Wong PH; Miller J; Bachmann K; Marbury T; Hoelscher D; Cavanaugh PF; Gottesdiener K
    J Clin Pharmacol; 2009 Oct; 49(10):1202-9. PubMed ID: 19783714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.